title: Adenosine and angiotensin system interact in the regulation of renal microcirculation in humans.
abstract: We sought to evaluate the possible interaction between the adenosine and angiotensin systems in the regulation of renal microcirculation in humans. Twenty normotensive patients entered the study. Ten patients (group 1) were pretreated with 50 mg of captopril, an inhibitor of angiotensin-converting enzyme, whereas 10 patients (group 2) were pretreated with placebo. Incremental doses of adenosine (from 10(-5) to 1 mg) were injected into a renal artery to all patients at 5-min intervals. Adenosine injection reduced mean renal blood flow velocity in both groups (from 17.3+/-2.8 and 16.7+/-2 cm/s to 5.1+/-1.1 and 3.8+/-0.8 cm/s, in groups 1 and 2, respectively). The decrease in flow velocity was immediate after adenosine, and its duration was proportional to dosage (y = 3.05 x -2.7; R2 = 0.46; p < 0.01). However, group 1 had a slope of regression lower than group 2 (2.37 vs. 3.82 s; p < 0.03). The index of renal resistance (mean arterial pressure/mean blood flow velocity) increased linearly in both groups with adenosine, but group I showed a lower slope of increment (2.77 vs. 5.57 mm Hg/cm/s; p < 0.01). Adenosine administration induced a marked and transient increase in human renal resistance. This vasoconstrictive effect of adenosine was blunted by captopril pretreatment.
authors.affiliation: CNR Institute of Clinical Physiology, Pisa, Italy. paolomar@ifc.pi.cnr.it
authors.forename: P
authors.initials: P
authors.lastname: Marraccini
authors.forename: S
authors.initials: S
authors.lastname: Fedele
authors.forename: E
authors.initials: E
authors.lastname: Orsini
authors.forename: E
authors.initials: E
authors.lastname: Gliozheni
authors.forename: G
authors.initials: G
authors.lastname: Djukic
authors.forename: A
authors.initials: A
authors.lastname: Mazzarisi
authors.forename: L
authors.initials: L
authors.lastname: Serasini
authors.forename: M
authors.initials: M
authors.lastname: Marzilli
authors.forename: A
authors.initials: A
authors.lastname: L'Abbate
mesh_terms: D000241:Adenosine / Q000494:pharmacology*; D000704:Analysis of Variance; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000809:Angiotensins / Q000378:metabolism*; D002216:Captopril / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D012079:Renal Circulation / Q000187:drug effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D002216:Captopril; D000241:Adenosine